Font Size: a A A
Keyword [activator inhibitor-1]
Result: 81 - 100 | Page: 5 of 10
81. Effects Of Salvia Miltiorrhiza And Prostaglandin E1 On Hepatic Veno-occlusive Disease After Haemotopoietic Stem Cell Transplantation
82. The Effects Of Native And Oxidized High Density Lipoprotein On Some Secretive Functions Of Endothelial Cells
83. The Effects Of CRP On The Expression Of PGI2,PAI-1 In ECV304 Cells
84. Effect Of Disc Displacement On MRNA Expression Of Urokinase Plasminogen Activator And Its Inhibitor-1 In Synovium Of TMJ
85. Relationship Between Sepsis And A 4G/5G Polymorphism Within The Promoter Region Of Plasminogen Activator Inhibitor-1 (PAI-1) Gene
86. Study On The Relationship Between Plasminogen Activator Inhibitor-1(PAI-1) Activity And The Recent Prognosis Of Patients With Non-ST Elevation Acute Coronary Syndrome
87. Detection And Signification Of Relationship Between Angiotensin Ⅱ Type1 Receptor And Plasminogen Activator Inhibitor-1 Genetic Polymorphism In Chronic Pulmonary Heart Disease
88. The Effect And Mechanism Of PercuSurge Distal Protection Device In Percutaneous Coronary Intervention In Acute Myocardial Infarction
89. The Role Of The 4G/5G Polymorphism Of The PAI-1 Gene In Airway Remodeling
90. The Changes Of Fibrinolysis And Its Relationship With Type 2 Diabetic Macro-vascular Complication
91. Expression And Signification Of The Type-1 Inhibitor Of Plasminogen Activator(PAI-1),Transforming Growth Factorβ1(TGF-β1) In Cervical Carcinoma
92. The Prevalence Of 4G5G Polymorphism Of Plasminogen Activator Inhibitor-1 (PAI-1) Gene In Polycystic Ovarian Syndrome And Its Association With Plasma PAI-1 Levels
93. The Study Of Relationships Between Serum C-Reactive Protein,the Activity Of Fibrinolytic System In Acute Cerebral Infarction And Different Type Of Syndrome Of TCM
94. The Preventive And Therapeutic Effects Of Valsartan And LMWH On Diabetic Nephropathy And Its Mechanisms
95. The Correlation Of Fibrinolytic Activation, Lipoprotein(a) And Coronary Arterial Thrombosis
96. Correlation Of Rennin Angiotensin System And Fibrinolytic System In Patients With Acute Coronary Syndrome
97. Plasma Concentrations Of Matrix Metalloproteinase-9 And Plasminogen Activator Inhibitor-1 In Acute Coronary Syndromes
98. The Renal Protection Of Captopril And Valsartan In Artherosclerosis Rabbit
99. The Effects Of Aristolochic Acid On Human Umbilical Vein Endothelial Cells
100. Role Of Thrombomodulin And Plasminogen Activator Inhibitor-1 In Diabetic Retinopathy
  <<First  <Prev  Next>  Last>>  Jump to